![](/img/cover-not-exists.png)
574 Cardiovascular safety of combination treatment with mirabegron and solifenacin in patients with overactive bladder in a randomised, double-blind, dose-ranging, Phase II study (Symphony)
Abrams, P., Kelleher, C., Staskin, D., Kay, R., Martina, R., Newgreen, D., Paireddy, A., Van Maanen, R., Ridder, A.Volume:
13
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(14)60565-0
Date:
April, 2014
File:
PDF, 2.32 MB
english, 2014